PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 30626305-14 2018 In conclusion, the AESOP 2015 has shown enterococcal bacteraemias in Australia are frequently caused by polyclonal ampicillin-resistant high-level gentamicin resistant vanA or vanB E. faecium which have limited treatment options. Ampicillin 115-125 Vancomycin Teicoplanin A-type resistance protein VanA / D-alanine--D-alanine ligase Enterococcus faecium 168-172 32988338-14 2020 In 2019, AESOP has shown that enterococcal bacteraemias in Australia are frequently caused by polyclonal ampicillin-resistant high-level gentamicin-resistant vanA or vanB E. faecium which have limited treatment options. Ampicillin 105-115 Vancomycin Teicoplanin A-type resistance protein VanA / D-alanine--D-alanine ligase Enterococcus faecium 158-162 32178603-14 2020 The AESOP 2018 study has shown that enterococcal bacteraemias in Australia are frequently caused by polyclonal ampicillin-resistant high-level gentamicin-resistant vanA- or vanB-harbouring E. faecium which have limited treatment options. Ampicillin 111-121 Vancomycin Teicoplanin A-type resistance protein VanA / D-alanine--D-alanine ligase Enterococcus faecium 164-168 31522664-14 2019 The AESOP 2017 has shown enterococcal bacteraemias in Australia are frequently caused by polyclonal ampicillin-resistant high-level gentamicin resistant vanA or vanB E. faecium which have limited treatment options. Ampicillin 100-110 Vancomycin Teicoplanin A-type resistance protein VanA / D-alanine--D-alanine ligase Enterococcus faecium 153-157 30632359-14 2018 The AESOP 2016 has shown enterococcal bacteraemias in Australia are frequently caused by polyclonal ampicillin-resistant high-level gentamicin resistant vanA or vanB E. faecium which have limited treatment options. Ampicillin 100-110 Vancomycin Teicoplanin A-type resistance protein VanA / D-alanine--D-alanine ligase Enterococcus faecium 153-157 11185546-0 2000 First report of ampicillin and glycopeptide resistant Enterococcus faecium VanA bacteraemia in Greece. Ampicillin 16-26 Vancomycin Teicoplanin A-type resistance protein VanA / D-alanine--D-alanine ligase Enterococcus faecium 75-79 27522135-13 2016 In conclusion, the AESOP 2014 has shown enterococcal bacteraemias in Australia are frequently caused by polyclonal ampicillin-resistant high-level gentamicin resistant vanA or vanB E. faecium, which have limited treatment options. Ampicillin 115-125 Vancomycin Teicoplanin A-type resistance protein VanA / D-alanine--D-alanine ligase Enterococcus faecium 168-172 24518625-5 2014 RESULTS: All isolates were identified as vancomycin/ampicillin resistant E. faecium carrying the vanA gene. Ampicillin 52-62 Vancomycin Teicoplanin A-type resistance protein VanA / D-alanine--D-alanine ligase Enterococcus faecium 97-101